News

Scottish Medicines Consortium to assess nusinersen for all types of 5q SMA

Scottish Medicines Consortium to assess nusinersen for all types of 5q SMAThe Scottish Medicines Consortium will be assessing nusinersen for the treatment of 5q SMA.

This means they will consider the case for SMA Types 1, 2, 3 and 4.

SMA Support UK, MDUK and The SMA Trust have been invited to provide a Patient Group Submission by 5th February 2018. We will be in touch with people with SMA and families across Scotland as well as with TreatSMA for their input.

Leave a Reply

Your email address will not be published. Required fields are marked *